Bio-Techne Stock Average Annual Return 10 Years
Growth of $10,000.00
With Dividends Reinvested Into TECH


Also see:
TECH stock yearly return 2014
TECH stock yearly return 2015
TECH stock yearly return 2016
TECH stock yearly return 2017
TECH stock yearly return 2018
TECH stock yearly return 2019
TECH stock yearly return 2020
TECH stock yearly return 2021
TECH stock yearly return 2022
TECH stock yearly return 2023
TECH YTD return
Compare TECH average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 04/23/2014
End date: 04/22/2024
Start price/share: $21.42
End price/share: $62.80
Starting shares: 466.85
Ending shares: 505.28
Dividends reinvested/share: $3.20
Total return: 217.32%
TECH Average Annual Return: 12.23%
Starting investment: $10,000.00
Ending investment: $31,722.27


Bio-Techne Stock average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. The Bio-Techne Stock average annual return 10 years is shown above.

The Average Annual Return on the Bio-Techne Stock average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether Bio-Techne Stock average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the TECH average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree TECH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bio-Techne (TECH) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

TELA Average Annual Return
TENX Average Annual Return
TERN Average Annual Return
TEVA Average Annual Return
TFFP Average Annual Return
TFX Average Annual Return
TGTX Average Annual Return
THAR Average Annual Return
THC Average Annual Return
THMO Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Bio-Techne (TECH) ranks in the top 25% of all stocks whose returns we have reviewed.
What has the average annual return been for TECH over the past ten years?
✔️Accepted answer: The ten year TECH average annual return has been 12.23% with dividends reinvested.

When you say 'with dividends reinvested' what does that mean?
✔️Accepted answer: That means that each time the stock goes ex-dividend, the average annual return calculation then factors in how that dividend amount could have been reinvested into more shares of TECH at the then-current price — often this is referred to as 'compounding' and is very important when considering average annual return over a long period like a full decade.

What start date was used in your TECH average annual return calculation?
✔️Accepted answer: The start date was 04/23/2014.

What end date was used in your TECH average annual return calculation?
✔️Accepted answer: The end date was 04/22/2024.

If I had invested $10,000 into TECH ten years ago, how much would I have today?
✔️Accepted answer: With dividends reinvested, as of 04/22/2024, you would have $31,722.27.

What does that work out to on a total return basis?
✔️Accepted answer: The TECH ten year total return ending 04/22/2024 works out to 217.32%.


Also see:
TECH stock yearly return 2014
TECH stock yearly return 2015
TECH stock yearly return 2016
TECH stock yearly return 2017
TECH stock yearly return 2018
TECH stock yearly return 2019
TECH stock yearly return 2020
TECH stock yearly return 2021
TECH stock yearly return 2022
TECH stock yearly return 2023
TECH YTD return
 

Bio-Techne Stock Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.